185 related articles for article (PubMed ID: 37791560)
1. Progress in controllable bioorthogonal catalysis for prodrug activation.
Liu X; Huang T; Chen Z; Yang H
Chem Commun (Camb); 2023 Oct; 59(84):12548-12559. PubMed ID: 37791560
[TBL] [Abstract][Full Text] [Related]
2. In situ activation of therapeutics through bioorthogonal catalysis.
Wang W; Zhang X; Huang R; Hirschbiegel CM; Wang H; Ding Y; Rotello VM
Adv Drug Deliv Rev; 2021 Sep; 176():113893. PubMed ID: 34333074
[TBL] [Abstract][Full Text] [Related]
3. Biodegradable nanoemulsion-based bioorthogonal nanocatalysts for intracellular generation of anticancer therapeutics.
Nabawy A; Gupta A; Jiang M; Hirschbiegel CM; Fedeli S; Chattopadhyay AN; Park J; Zhang X; Liu L; Rotello VM
Nanoscale; 2023 Aug; 15(33):13595-13602. PubMed ID: 37554065
[TBL] [Abstract][Full Text] [Related]
4. A DNA-Gated and Self-Protected Bioorthogonal Catalyst for Nanozyme-Assisted Safe Cancer Therapy.
Zhang Y; Zhang L; Wang W; Deng Q; Liu M; Zhu Z; Liu H; Ren J; Qu X
Angew Chem Int Ed Engl; 2023 Aug; 62(32):e202306395. PubMed ID: 37268594
[TBL] [Abstract][Full Text] [Related]
5. Degradable ZnS-Supported Bioorthogonal Nanozymes with Enhanced Catalytic Activity for Intracellular Activation of Therapeutics.
Zhang X; Lin S; Huang R; Gupta A; Fedeli S; Cao-Milán R; Luther DC; Liu Y; Jiang M; Li G; Rondon B; Wei H; Rotello VM
J Am Chem Soc; 2022 Jul; 144(28):12893-12900. PubMed ID: 35786910
[TBL] [Abstract][Full Text] [Related]
6. Nanomaterial-based bioorthogonal nanozymes for biological applications.
Fedeli S; Im J; Gopalakrishnan S; Elia JL; Gupta A; Kim D; Rotello VM
Chem Soc Rev; 2021 Dec; 50(24):13467-13480. PubMed ID: 34787131
[TBL] [Abstract][Full Text] [Related]
7. Intracellular Activation of Anticancer Therapeutics Using Polymeric Bioorthogonal Nanocatalysts.
Zhang X; Landis RF; Keshri P; Cao-Milán R; Luther DC; Gopalakrishnan S; Liu Y; Huang R; Li G; Malassiné M; Uddin I; Rondon B; Rotello VM
Adv Healthc Mater; 2021 Mar; 10(5):e2001627. PubMed ID: 33314745
[TBL] [Abstract][Full Text] [Related]
8. Bioorthogonal nanozymes: an emerging strategy for disease therapy.
Zhang Z; Fan K
Nanoscale; 2022 Dec; 15(1):41-62. PubMed ID: 36512377
[TBL] [Abstract][Full Text] [Related]
9. Transition Metal Ru(II) Catalysts Immobilized Nanoreactors for Conditional Bioorthogonal Catalysis in Cells.
Gao Z; Li Y; Xing J; Lu Y; Shao Q; Hu J; Zhao S; He W; Sun B
ACS Appl Mater Interfaces; 2024 Apr; 16(13):15870-15878. PubMed ID: 38520329
[TBL] [Abstract][Full Text] [Related]
10. Inorganic nanoparticles as scaffolds for bioorthogonal catalysts.
Hirschbiegel CM; Zhang X; Huang R; Cicek YA; Fedeli S; Rotello VM
Adv Drug Deliv Rev; 2023 Apr; 195():114730. PubMed ID: 36791809
[TBL] [Abstract][Full Text] [Related]
11. Transition metal catalysts for the bioorthogonal synthesis of bioactive agents.
van de L'Isle MON; Ortega-Liebana MC; Unciti-Broceta A
Curr Opin Chem Biol; 2021 Apr; 61():32-42. PubMed ID: 33147552
[TBL] [Abstract][Full Text] [Related]
12. Designer Nanoreactors for Bioorthogonal Catalysis.
Kumar A; Lee IS
Acc Chem Res; 2024 Feb; 57(3):413-427. PubMed ID: 38243820
[TBL] [Abstract][Full Text] [Related]
13. Liquid Metal as Bioinspired and Unusual Modulator in Bioorthogonal Catalysis for Tumor Inhibition Therapy.
Zhang L; Sang Y; Liu Z; Wang W; Liu Z; Deng Q; You Y; Ren J; Qu X
Angew Chem Int Ed Engl; 2023 Feb; 62(9):e202218159. PubMed ID: 36578232
[TBL] [Abstract][Full Text] [Related]
14. A narrative review: progress in transition metal-mediated bioorthogonal catalysis for the treatment of solid tumors.
Wan X; Zhang Y; Nie Y; Zhang K; Jin Z; Zhang Z; Gan L; Liu X; He J
Transl Cancer Res; 2023 Aug; 12(8):2181-2196. PubMed ID: 37701121
[TBL] [Abstract][Full Text] [Related]
15. Bioorthogonal catalytic patch.
Chen Z; Li H; Bian Y; Wang Z; Chen G; Zhang X; Miao Y; Wen D; Wang J; Wan G; Zeng Y; Abdou P; Fang J; Li S; Sun CJ; Gu Z
Nat Nanotechnol; 2021 Aug; 16(8):933-941. PubMed ID: 33972760
[TBL] [Abstract][Full Text] [Related]
16. Designed heterogeneous palladium catalysts for reversible light-controlled bioorthogonal catalysis in living cells.
Wang F; Zhang Y; Du Z; Ren J; Qu X
Nat Commun; 2018 Mar; 9(1):1209. PubMed ID: 29572444
[TBL] [Abstract][Full Text] [Related]
17. Erythrocyte-mediated delivery of bioorthogonal nanozymes for selective targeting of bacterial infections.
Gupta A; Das R; Makabenta JM; Gupta A; Zhang X; Jeon T; Huang R; Liu Y; Gopalakrishnan S; Milán RC; Rotello VM
Mater Horiz; 2021 Nov; 8(12):3424-3431. PubMed ID: 34700339
[TBL] [Abstract][Full Text] [Related]
18. Activation and Delivery of Tetrazine-Responsive Bioorthogonal Prodrugs.
Wang Y; Zhang C; Wu H; Feng P
Molecules; 2020 Nov; 25(23):. PubMed ID: 33266075
[TBL] [Abstract][Full Text] [Related]
19. Bioorthogonal nanozymes for breast cancer imaging and therapy.
Zhang X; Liu Y; Doungchawee J; Castellanos-García LJ; Sikora KN; Jeon T; Goswami R; Fedeli S; Gupta A; Huang R; Hirschbiegel CM; Cao-Milán R; Majhi PKD; Cicek YA; Liu L; Jerry DJ; Vachet RW; Rotello VM
J Control Release; 2023 May; 357():31-39. PubMed ID: 36948419
[TBL] [Abstract][Full Text] [Related]
20. Modular Fabrication of Bioorthogonal Nanozymes for Biomedical Applications.
Huang R; Hirschbiegel CM; Lehot V; Liu L; Cicek YA; Rotello VM
Adv Mater; 2024 Mar; 36(10):e2300943. PubMed ID: 37042795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
